In recent years, some authors have reported the transmission 40 of S. stercoralis from infected donors to recipients.
2-5 Interestingly, most cases were 41 diagnosed when recipients presented with hyperinfection syndrome and donors were found 42 to have S. stercoralis on retrospective testing. 43
Routine diagnosis of S. stercoralis is based on parasitological methods and serology, 44 although their performance is far from optimal.
6 Real-time polymerase chain reaction (RT-45 PCR) has emerged as a promising diagnostic tool for S. stercoralis. 7 Little is known about its 46 potential role in subjects with a depressed cellular immune response, such as SOT 47
recipients. 48
We describe the usefulness and potential role of RT-PCR for the diagnosis of S. 49 stercoralis in immunosuppressed individuals. This technique was used to detect the 50 transmission of the parasite from an infected donor to two SOT recipients. 51 A 45-year-old female patient from Paraguay was admitted to a Spanish hospital with 54 one-month history of dyspnea, dry cough and fever. The patient had a previous diagnosis of 55 systemic lupus erythematosus with nephropathy and she was under chronic therapy with 56 steroids and mycophenolate mofetil. Upon admission, a chest x-ray showed bilateral 57 alveolo-interstitial infiltrates and her blood tests revealed an acute renal failure and a non-58 hemolytic anemia. 59
On suspicion of a lupus flare the patient received a 500 mg methylprednisolone 60 bolus. The patient's respiratory condition progressively worsened, requiring admission to 61 the intensive care unit. Piperacillin-tazobactam, levofloxacin and trimetoprim-62 sulfametoxazol were added. Shortly after, hemoptysis developed with acute respiratory 63 failure, prompting intubation and bronchoscopy which showed active bleeding in the left 64
lung. An angio-CT revealed extensive peribronchovascular infiltrates suggestive of alveolar 65 hemorrhage without malformations of bronchial arteries. An endovascular embolization of a 66 left bronchial artery branch was performed. 67
The patient was then treated with methylprednisolone, rituximab, mycophenolate 68 mofetil and 4 days of immunoglobulins without clinical improvement. Broad-spectrum 69 antibiotics were maintained. Ten days after admission, the patient developed a sudden 70 hypertensive emergency associated with coma and non-reactive bradycardia. A brain CT 71 revealed bilateral intracerebral hemorrhage and the patient finally died after evolving to 72 brain death. 73 F o r P e e r R e v i e w then performed using the commercial serological test IVD-ELISA (IVD Research, Carlsbad, 76 CA), which detects IgG antibodies by using somatic antigens from S. stercoralis larvae. A 77 positive result (i = 4.49 U/µL) was received on day 9 post-transplant. Transplant teams and 78 organ procurement organizations were alerted. 79
Recipient 1 80
A 66-year old female patient with end-stage hepatic cirrhosis by hepatitis C virus 81 infection underwent orthotopic liver transplantation. She was born and had lived in Spain 82 during all her life. Immunosuppressive therapy was initiated with basiliximab, 83 methylprednisolone and mycophenolate mofetil. 84
On day 9, after receiving the positive result of S. stercoralis serology from the donor, 85 ivermectin was empirically initiated at a dose of 200 µg/kg/day. Two stool samples were 86 collected, but no larvae were found after direct examination. S. stercoralis serology was 87 negative (i = 0.035 U/µl). The patient received 14 days of ivermectin and stools were 88 monitored for larvae, which were not found on direct examination. 89
The patient followed a severe clinical course, presenting multiple complications ten 90 days after ending ivermectin. This case adds to the existing reports of S. stercoralis transmission from donors to 132 SOT recipients, 2-5 but there are some important differences in our case. All donor-to-133 recipients transmissions described so far were investigated when at least one SOT recipient 134 presented with severe strongyloidiasis. Most cases were diagnosed 2-3 months after 135 transplantation, 2 probably after a sufficient period of immunosuppressive therapy. 136
However, in our case, the donor was diagnosed post-mortem with a positive serology, which 137 prompted investigations and empirical treatment of SOT recipients. One could even 138 hypothesize that the donor died of hyperinfection syndrome, missed by the treating 139
physicians. An alternative route of infection, in contrast to the common presentation of 140 strongyloidiasis, could explain the shorter pre-patent period shown in these cases. 141
Interestingly, recipient 2 presented with alveolar hemorrhage and bilateral lung 142 infiltrates shortly after transplantation, rapidly improving after adding ivermectin and 143
albendazole. This suggests the development of an acute hyperinfection syndrome. 144
Unfortunately, we were unable to keep enough sample of bronchoalveolar lavage fluid for 145
RT-PCR, which may have provided a definite diagnosis. In contrast, recipient 1 did not have 146 symptoms attributable to strongyloidiasis prior to ivermectin treatment. Possible reasons 147 for this are a higher larvae burden in the heart recipient due to contiguity in the surgical 148 F o r P e e r R e v i e w field and that recipient 2 had previously received high dose steroids for myocarditis 149
treatment. 150
Both recipients had negative stool microscopy and serology, which occurs in acute 151 infections and illustrates the challenges that clinicians face with S. stercoralis diagnosis in 152 immunosuppressed individuals. Apart from the low sensitivity of direct fecal examination, 153 serological tests may provide a false negative result in acute cases, especially in 154 immunocompromised patients. 6 The possibility of intermittent low larvae output, especially 155 in acute phases of infection, adds more complexity to diagnostic efforts. 156
Although RT-PCR in stool is still under development, some studies have shown high 157 sensitivity and specificity in S. stercoralis diagnosis.
7, 9 However, this method may lose power 158 if low larvae output, 10 which can be overcome by stool concentration, as illustrated by 159
Saugar and colleagues.
8 Despite the need of further validation of RT-PCR for S. strongyloides 160 detection, our report suggests that this technique could reduce the time to diagnosis and 161 increase the diagnostic yield in possible donor-to-recipient transmissions. 162
The American Society of Transplantation recommends screening S. stercoralis in 163 donors and candidate recipients from endemic areas and/or with unexplained 164 eosinophilia.
11 However, these guidelines are often not followed by physicians worldwide, 165 although a rapid detection can prompt antiparasitic treatment and decrease the risk of 166 severe strongyloidiasis. A recent publication including data from the New York Organ Donor 167
Network showed that among 233 eligible potential donors screened for S. stercoralis, 10 168 (4.3%) had a positive serological result. Of note, no cases of infection occurred among those 169 recipients who received an organ from infected donors, after receiving prophylaxis. Routine diagnosis of S. stercoralis is based on parasitological methods and serology, 45 although their performance is far from optimal.
6 Real-time polymerase chain reaction (RT-46 PCR) has emerged as a promising diagnostic tool for S. stercoralis. 7 Little is known about its 47 potential role in subjects with a depressed cellular immune response, such as SOT 48
recipients. 49
We describe the usefulness and potential role of RT-PCR for the diagnosis of S. 50 stercoralis in immunosuppressed individuals. This technique was used to detect the 51 transmission of the parasite from an infected donor to two SOT recipients. 52 On day 9, after receiving the positive result of S. stercoralis serology from the donor, 86 ivermectin was empirically initiated at a dose of 200 µg/kg/day. Two stool samples were 87 collected, but no larvae were found after direct examination. S. stercoralis serology was 88 negative (i = 0.035 U/µl). The patient received 14 days of ivermectin and stools were 89 monitored for larvae, which were not found on direct examination. 90
The patient followed a severe clinical course, presenting multiple complications ten 91 days after ending ivermectin. She was diagnosed with acute hepatitis by type 1 and 2 herpes 92 serological tests may provide a false negative result in acute cases, especially in 155 immunocompromised patients. 6 The possibility of intermittent low larvae output, especially 156 in acute phases of infection, adds more complexity to diagnostic efforts. 157
Although RT-PCR in stool is still under development, some studies have shown high 158 sensitivity and specificity in S. stercoralis diagnosis.
7, 9 However, this method may lose power 159 if low larvae output, 10 which can be overcome by stool concentration, as illustrated by 160
8 Despite the need of further validation of RT-PCR for S. strongyloides 161 detection, our report suggests that this technique could reduce the time to diagnosis and 162 increase the diagnostic yield in possible donor-to-recipient transmissions. 163
The American Society of Transplantation recommends screening S. stercoralis in 164 donors and candidate recipients from endemic areas and/or with unexplained 165 eosinophilia.
11 However, these guidelines are often not followed by physicians worldwide, 166 although a rapid detection can prompt antiparasitic treatment and decrease the risk of 167 severe strongyloidiasis. A recent publication including data from the New York Organ Donor 168
Network showed that among 233 eligible potential donors screened for S. stercoralis, 10 169 (4.3%) had a positive serological result. Of note, no cases of infection occurred among those 170 recipients who received an organ from infected donors, after receiving prophylaxis. 
